SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4: In addition, in individuals with an α1AT deficiency, when medicated with α1AT augmentation treatment, α1AT has been demonstrated to govern the overall metalloproteinase-2 (MMP2) and cathepsin B level [19].